Novavax (NVAX) Rises Despite U.S. Coronavirus Vaccine Study DelayZacks Investment Research • 12/01/20
Novavax's Late-Stage COVID Vaccine Trial in U.S. Delayed Again: Should Investors Worry?The Motley Fool • 12/01/20
Novavax Reverses Earlier Losses As It Plans U.S. Covid Vaccine TestInvestors Business Daily • 11/30/20
Novavax climbs 11% after announcing data from UK vaccine trial are expected in early 2021Business Insider • 11/30/20
Bill Gates Says AstraZeneca, Johnson & Johnson, Novavax COVID-19 Vaccines All Likely To Prove 'Very Efficacious And Safe' By FebruaryBenzinga • 11/23/20